Situs variation and cardiovascular anomalies in the transgenic mouse insertional mutation,inv

✍ Scribed by Morishima, Masae; Yasui, Hiroshi; Nakazawa, Makoto; Ando, Masahiko; Ishibashi, Masahiko; Takao, Atsuyoshi

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 281 KB
• Volume: 57
• Category: Article
• ISSN: 0040-3709
• DOI: 10.1002/(sici)1096-9926(199806)57:6<302::aid-tera3>3.0.co;2-y

✦ Synopsis

The inv mouse was reported as a novel strain with situs inversus Yokoyama et al., '93), and a few cases with heterotaxy were found in homozygotes. The original report by Yokoyama et al. described the location of the heart and the stomach using the index of arrangement of body structure. We newly examined 40 homozygous offspring for phenotypes of visceroatrial situs and the incidence of cardiovascular anomalies making use of morphological details defined in each organ structure. According to the arrangement of each organ, which ranged from the almost complete form of situs inversus to left isomerism, visceroatrial situs was classified into four categories: Situs inversus (4 cases), "variation type" of situs (17 cases), "abdominal heterotaxy" (15 cases), and visceroatrial heterotaxy (4 cases). In offspring with situs inversus, only one had aortic stenosis (25%). Seven with the "variation type" of situs had cardiovascular anomalies, such as aortic stenosis, endocardial cushion defect, and posterior vena cava interruption (41%). All 15 offspring with "abdominal heterotaxy" had anomalies of the posterior vena cava, and three of them also had tetralogy of Fallot. The remaining four with visceroatrial heterotaxy had endocardial cushion defect, which was associated with outflow tract anomaly in two cases (i.e. tetralogy of Fallot in one case and transportation of the great arteries in the other). These results revealed that visceroatrial heterotaxy frequently occurred in the inv homozygotes, especially in the abdomen, and often showed a propensity to left isomerism with posterior vena cava interruption.